Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$926K Buy
7,203
+59
+0.8% +$6.91K 0.53% 52
2026
Q1
$859K Sell
7,144
-499
-7% -$57.6K 0.57% 49
2025
Q4
$805K Hold
7,643
0.55% 51
2025
Q3
$641K Buy
7,643
+500
+7% +$41.2K 0.45% 59
2025
Q2
$565K Buy
7,143
+694
+11% +$55.2K 0.45% 61
2025
Q1
$579K Buy
6,449
+1,001
+18% +$93.5K 0.57% 51
2024
Q4
$542K Buy
+5,448
New +$562K 0.6% 45

Other funds holding MRK

M.E. Allison & Co's MRK Position: Q2 2026 in Review

M.E. Allison & Co increased its Merck (MRK) stake by 0.83% in Q2 2026, buying an estimated $6.91K and bringing the position to 7,203 shares worth $926K. The position accounts for 0.53% of the portfolio, ranked #52.

M.E. Allison & Co first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 711 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • M.E. Allison & Co held 7,203 shares of Merck worth $926K as of Q2 2026.
  • M.E. Allison & Co bought 59 Merck shares in Q2 2026, an estimated $6.91K.
  • Merck made up 0.53% of M.E. Allison & Co's portfolio in Q2 2026, its #52 holding.
  • M.E. Allison & Co first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 711 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on M.E. Allison & Co's 13F filing for Q2 2026, filed 7 Jul 2026.